Research on induced pluripotent stem cells and the application in ocular tissues
Author:
Corresponding Author:

Affiliation:

1Key Laboratory for Regenerative Medicine, Ministry of Education, Jinan University, Guangzhou 510632, Guangdong Province, China;
2Eye Institute, Medical College of Jinan University, Guangzhou 510632, Guangdong Province, China;
3Department of Ophthalmology, the First Clinical Medical College of Jinan University, Guangzhou 510632, Guangdong Province, China

Clc Number:

Fund Project:

Supported by the National Natural Science Foundation of China (No. 81371689); Natural Science Foundation of Guangdong Province (S2013010013391).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Induced pluripotent stem cells (iPSCs) were firstly induced from mouse fibroblasts since 2006, and then the research on iPSCs had made great progress in the following years. iPSCs were established from different somatic cells through DNA, RNA, protein or small molecule pathways and transduction vehicles. With continuous improvement of technology on reprogramming, the induction of iPSCs became more secure and effective, and showed enormous promise for clinical applications. We reviewed different reprogramming of somatic cells, four kinds of pathways of reprogramming and three types of transduction vehicles, and discuss the research of iPSCs in ophthalmology and the prospect of iPSCs applications.

    Reference
    Related
    Cited by
Get Citation

Xiao-Ling Guo, Jian-Su Chen. Research on induced pluripotent stem cells and the application in ocular tissues. Int J Ophthalmol, 2015,8(4):818-825

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:March 11,2014
  • Revised:February 02,2015
  • Adopted:February 02,2015
  • Online: July 27,2015
  • Published: